Gadodiamide
From Wikipedia, the free encyclopedia
Gadodiamide
|
|
Systematic (IUPAC) name | |
2-[bis[2-(carboxylatomethyl-(methylcarbamoylmethyl)amino)ethyl]amino]acetate; gadolinium(+3) cation | |
Identifiers | |
CAS number | |
ATC code | ? |
PubChem | |
Chemical data | |
Formula | C16H28GdN5O9 |
Mol. mass | 591.672g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Protein binding | negligible |
Metabolism | not metabolized |
Half life | 77.8 minutes |
Excretion | renal |
Therapeutic considerations | |
Pregnancy cat. |
C(US) |
Legal status | |
Routes | i.v. |
Gadodiamide is a gadolinium based contrast agent used in MR imaging procedures to assist in the visualization of blood vessels. It is commonly marketed under the trade name Omniscan.
[edit] Uses
Gadodiamide is used to visualize blood vessels during MRI procedures. The use of gadodiamide in these scans allows for the diagnosis of intracranial lesions or blood-brain barrier anomolies.[1] It is a high osmolarity contrast agent at 789 mOsmol per kg of water.
Gadolinium based agents may cause a toxic reaction known as NSF in patients with kidney problems.
[edit] References
- ^ Gadodiamide Drug Information. Drugs.com Professional. Micromedex (9 January 2007). Retrieved on February 19, 2007.